With the analysis among 187,740 patents, we discovered top 445 key players by total patent application. F. Hoffmann-La Roche Ltd., Novartis AG, Genentech, Inc. are dominant in this area. They take 5.62% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 3,396
California, United States
Patent: 3,355
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2,283
New York, United States
Patent: 2,167
New York, United States
Patent: 2,159
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 1,651
Indiana, United States
Patent: 1,544
Hessen, Germany
Patent: 1,510
California, United States
Patent: 1,489
With the analysis among 4,694 patents, we discovered top 335 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Biosplice Therapeutics, Inc., NantOmics LLC are active in this area.
Institut National de la Santé et de la Recherche Médicale
Biosplice Therapeutics, Inc.
California, United States
Patent: 191
California, United States
Patent: 100
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 84
Massachusetts, United States
Patent: 52
ImmunoMet Therapeutics, Inc.
Texas, United States
Patent: 50
New Jersey, United States
Patent: 45
Illinois, United States
Patent: 42
Massachusetts, United States
Patent: 42
With the analysis among related 30,217 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Immatics Biotechnologies GmbH, Pfizer Inc., Regents of the University of California take 4.10% of patent filing during this period.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 538
New York, United States
Patent: 375
Regents of the University of California
California, United States
Patent: 326
The Board of Regents of The University of Texas System
Texas, United States
Patent: 226
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 221
Basel-Stadt, Switzerland
Patent: 220
Institut National de la Santé et de la Recherche Médicale
F. Hoffmann-La Roche Ltd.
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 161
New York, United States
Patent: 157
With the analysis among related 30,217 patents in last 5 years, we discover 44 new entrants. DRAGONFLY Therapeutics, Inc., Lunella Biotech Inc, Shattuck Labs, Inc. are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 84
Texas, United States
Patent: 42
Illinois, United States
Patent: 42
Herefordshire, United Kingdom
Patent: 29
Nanjing Bioheng Biotech Co., Ltd.
Jiangsu Sheng, China
Patent: 26
Beijing Cornerstone Life Technology Co., Ltd.
Beijing Shi, China
Patent: 23
Obsidian Therapeutics, Inc.
Massachusetts, United States
Patent: 22
Indapta Therapeutics, Inc.
California, United States
Patent: 20
With the analysis among 65,099 patents, we discovered top 272 universities and scientific research institutions by total patent application. The Johns Hopkins University, President & Fellows of Harvard College, Yale University are dominant in this area. They take 9.63% of the total patent filing.
The Johns Hopkins University
United States
Patent: 1,448
President & Fellows of Harvard College
Massachusetts, United States
Patent: 640
Connecticut, United States
Patent: 562
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 516
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 515
University of Southern California
California, United States
Patent: 449
North Carolina, United States
Patent: 443
Georgia, United States
Patent: 441
Baylor College of Medicine
Texas, United States
Patent: 435
University of South Florida